Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03713944
Title Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Big Ten Cancer Research Consortium
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
University of Virginia Health System Charlottesville Virginia 22908 United States Details
University of Wisconsin Madison Wisconsin 53705 United States Details
ProHealth Care Waukesha Wisconsin 53188 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field